SCHEMBL29410002

SCHEMBL29410002

CCOC(=O)c1c(Cl)cc(-c2ccc(C(C)(C)C)cc2)nc1C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
GAA P10253 4/20 0.47
POLB P06746 3/20 0.47
MAPT P10636 5/20 0.47
RAB9A P51151 3/20 0.47
NPC1 O15118 2/20 0.47
MEN1 O00255 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
KMT2A Q03164 1/20 0.47
HTT P42858 2/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
KDM4E B2RXH2 4/20 0.45
HPGD P15428 3/20 0.45
NPSR1 Q6W5P4 2/20 0.44
LMNA P02545 1/20 0.44
ALPL P05186 1/20 0.43
THRB P10828 3/20 0.42
TP53 P04637 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22712490 1.00 ALDH1A1 (0.55) ALDH1A1L3MBTL1GAAPOLBMAPT
SCHEMBL23605339 0.89 SMN1; SMN2 (0.48) ALDH1A1L3MBTL1POLBMAPTRAB9A
SCHEMBL38662117 0.83 AKR1C2 (0.47) ALDH1A1POLBMAPTRAB9ANPC1
SCHEMBL22712460 0.79 KDM4E (0.52) ALDH1A1L3MBTL1GAAPOLBMAPT
SCHEMBL30250379 0.79 KDM4E (0.52) ALDH1A1L3MBTL1GAAPOLBMAPT
SCHEMBL22712440 0.78 MAPT (0.40) ALDH1A1L3MBTL1GAAMAPTRAB9A
SCHEMBL29364817 0.78 MAPT (0.40) ALDH1A1L3MBTL1GAAMAPTRAB9A
SCHEMBL29368117 0.77 ALDH1A1 (0.47) ALDH1A1L3MBTL1GAAPOLBMAPT
SCHEMBL22712484 0.77 ALDH1A1 (0.47) ALDH1A1L3MBTL1GAAPOLBMAPT
SCHEMBL3342312 0.77 ALDH1A1 (0.54) ALDH1A1L3MBTL1GAAPOLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3968983-A1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS F. Hoffmann-La Roche AG (CH) 2022-03-23 EP disclosed